Skip to main content
main-content

Video+

All video interviews

02-22-2019 | Psychosocial care | ATTD 2019 | Article

Expert highlights: Psychologic issues influencing device uptake in teens with diabetes

Korey Hood outlines some psychologic issues that should be addressed to optimize the uptake of diabetes technologies by adolescents (4:46).

02-21-2019 | Hypoglycemia | ATTD 2019 | Article

Expert commentary: Gauging hypoglycemia risk in routine clinical practice

Simon Heller outlines some straightforward tactics for assessing people’s risk for hypoglycemia during routine consultations (2:49).

02-21-2019 | Psychosocial care | ATTD 2019 | Article

Expert highlights: Psychology and patient-reported outcome symposia at ATTD

Kath Barnard talks about why is it important to feature psychologic research and patient-reported outcomes at a diabetes technology conference (1:44).

02-19-2019 | Artificial pancreas systems | Video | Article

Video explainer: The DIY artificial pancreas

Engineer and endocrinologist Rayhan Lal, from Stanford University in California, USA, explains the phenomenon of DIY closed-loop insulin delivery and what to do if a patient wants to adopt it.

11-16-2018 | Dapagliflozin | Feature | Video

Researcher comment: DECLARE-TIMI 58

DECLARE-TIMI 58 steering committee member John Wilding talks us through the trial's findings (5:49).

11-10-2018 | Dapagliflozin | Feature | Video

Expert commentary: DECLARE-TIMI 58

Miles Fisher talks to medwireNews about the results of the dapagliflozin cardiovascular outcomes trial DECLARE-TIMI 58.

10-08-2018 | Diabetes prevention | EASD 2018 | Video

Expert commentary: The PREVIEW project

Amrit Lamba considers the rather mixed results of the PREVIEW project, and what they mean for primary care (3:40).

10-06-2018 | Insulin | EASD 2018 | Video

EASD 2018 expert commentary: Predictors of delayed insulin initiation in type 2 diabetes patients

Lori Berard comments on the results of a study that identifies barriers to basal insulin initiation and factors associated with insulin interruption among patients with type 2 diabetes (2:14).

10-06-2018 | Albiglutide | EASD 2018 | Video

Expert commentary: The HARMONY trial

John Wilding discusses the unexpected results of HARMONY, the albiglutide cardiovascular outcomes study (2:43).

10-05-2018 | Hyperglycemia | EASD 2018 | Video

A Canadian nurse’s view of the ADA/EASD guidelines

Nurse consultant and diabetes educator Lori Berard discusses the consensus report on managing hyperglycemia in people with type 2 diabetes (2:42).

10-04-2018 | Hyperglycemia | EASD 2018 | Video

The ADA/EASD consensus report: A view from primary care

Amrit Lamba gives his view of what the updated ADA/EASD hyperglycemia guidelines mean for primary care practitioners (6:08).

10-04-2018 | Hyperglycemia | EASD 2018 | Video

What’s new in the 2018 ADA/EASD hyperglycemia management consensus report

Hyperglycemia management in type 2 diabetes guidelines author Melanie Davies discusses the key updates in the 2018 edition, the evidence behind them, and the experience of being part of a trans-Atlantic consensus group (5:13).

10-03-2018 | UKPDS | EASD 2018 | Video

The far reaching effects of the UKPDS

Professor Miles Fisher talks about the how the UKPDS shook up the treatment landscape for people with diabetes and set the stage for modern clinical research (3:13).

06-27-2018 | SGLT2 inhibitors | ADA 2018 | Video

Expert commentary: SGLT2 inhibition in type 1 diabetes patients

John Wilding has been sitting on the fence about the prospects for SGLT2 inhibitors in type 1 diabetes. Is he swayed by the latest findings? (3:43)

06-27-2018 | SGLT2 inhibitors | ADA 2018 | Video

Expert commentary: SGLT2 inhibitors in type 1 diabetes

Lori Berard reflects on the latest evidence for SGLT2 inhibition as an adjunct to insulin in patients with type 1 diabetes (1:52).

06-27-2018 | Cardiovascular outcomes | ADA 2018 | Video

Expert commentary: A general practice view of the VADT findings

Kevin Fernando discusses the implications of the VADT 15-year findings for managing older patients with diabetes in primary care (2:22).

Read the accompanying news story here

06-26-2018 | Pathophysiology | ADA 2018 | Video

Expert commentary: Results from the pediatric medication arm of the RISE trial

Dana Dabelea discusses the RISE investigators’ findings about the physiology of type 2 diabetes in children and the effects of medication on its progression (7:38).

Read the accompanying news story here

06-26-2018 | Cardiovascular outcomes | ADA 2018 | Video

Expert commentary: Legacy cardioprotective effect of intensive glycemic control does not last

Medha Munshi comments on the VADT trial, showing that the cardioprotective effect of intensive glycemic control in patients with type 2 diabetes disappears after 15 years (3:04).

Read the accompanying news story here

03-16-2018 | Obesity | Editorial | Video

The updated Diabetes UK nutrition guidelines: an obesity specialist’s view

John Wilding explains how the latest update of the nutrition guidelines will help clinicians working with patients with obesity (1:53).

03-16-2018 | Diet | Editorial | Video

What’s new in the Diabetes UK nutrition guidelines

Registered Dietitian Pamela Dyson explains why the latest update of the nutrition guidelines is an important departure from previous versions (0:45).

image credits